Cited by 10Genetic Associations and EpidemiologyHypothalamic control of reproductive hormonesSexual Differentiation and Disorders

Genome-wide association study and polygenic risk scores of serum DHEAS levels in a Chilean children cohort

Open access
Miranda, José Patricio, Lardone, María Cecilia, Rodríguez, Fernando, Cutler, Gordon B, Santos, José Luis, Corvalán, Camila, Pereira, Ana, Mericq, Verónica·2022·The Journal of Clinical Endocrinology & Metabolism

Abstract

CONTEXT: Adrenarche reflects the developmental growth of the adrenal zona reticularis, which produces increasing adrenal androgen secretion (eg, dehydroepiandrosterone [DHEA]/dehydroepiandrosterone sulfate [DHEAS]) from approximately age 5 to 15 years. OBJECTIVE: We hypothesized that the study of the genetic determinants associated with variations in serum DHEAS during adrenarche might detect genetic variants influencing the rate or timing of this process. METHODS: Genome-wide genotyping was performed in participants of the Chilean pediatric Growth and Obesity Chilean Cohort Study (GOCS) cohort (n = 788). We evaluated the genetic determinants of DHEAS levels at the genome-wide level and in targeted genes associated with steroidogenesis. To corroborate our findings, we evaluated a polygenic risk score (PRS) for age at pubarche, based on the discovered variants, in children from the same cohort. RESULTS: We identified one significant variant at the genome-wide level in the full cohort, close to the GALR1 gene (P = 3.81 × 10-8). In addition, variants suggestive of association (P < 1 × 10-5) were observed in PRLR, PITX1, PTPRD, NR1H4, and BCL11B. Stratifying by sex, we found variants suggestive of association in SERBP1 and CAMTA1/VAMP3 for boys and near ZNF98, TRPC6, and SULT2A1 for girls. We also found significant reductions in age at pubarche in those children with higher PRS for greater DHEAS based on these newly identified variants. CONCLUSION: Our results disclose one variant associated with DHEAS concentrations at the level of genome-wide association study significance, and several variants with a suggestive association that may be involved in the genetic regulation of adrenarche.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/clinem/dgab814

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CYP17A1 catalyses the final step in the biosynthesis of the adrenal androgens DHEAS and ∆4-androstenedione.

    “Remarkably, the ACTH+PRL combined treatment selectively increased the expression of CYP17A1 , encoding the CYP17A1 enzyme which catalyses the final step in the biosynthesis of the adrenal androgens DHEAS and ∆ 4androstenedione (Fig. 2A, 3).”

    From ACTH and prolactin synergistically and selectively regulate CYP17 expression and adrenal androgen production in human foetal adrenal organ cultures (2023) · cites this paper as [38]

    The Association Analysis section lists CYP17A1 among genes involved in adrenal steroidogenesis, but does not assign it the final biosynthetic step. The Genome-wide Association Study of Log-Dehydroepiandrosterone Sulfate section instead says SULT2A1 mediates the conversion of DHEA to DHEAS; it does not establish the claimed role for CYP17A1 in producing ∆4-androstenedione. Page numbers are unavailable in our copy. (LLM, conf=0.82)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 75 · Cited by 10

Research works printed but not linked: 1

  1. Chen F, Knecht K, Leu C, et al. Partial agonist/antagonist prop- erties of androstenedione and 4-androsten-3beta,17beta-diol. J Steroid Biochem Mol Biol. 2004;91(4-5):247-257.

Authors
Miranda, J. P., Lardone, M. C., Rodríguez, F., Cutler, G. B., Santos, J. L., Corvalán, C., Pereira, A., & Mericq, V.
Affiliations
  • Pontificia Universidad Católica de Chile (CL)
  • University of Chile (CL)
  • Gordon Cutler Consultancy LLC, Deltaville, Virginia, USA
  • Institute of Maternal and Child Research, School of Medicine, Universidad de Chile, Santiago, Chile
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2021-11-08
Volume
107
Issue
4
Pages
e1727-e1738
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W3211748951
Cited by
10
References
75
Citations by year
2025: 4 · 2024: 2 · 2023: 3 · 2022: 1
FWCI
0.85
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Fondo Nacional de Desarrollo Científico y Tecnológico (1120326, 1190346, 1140447, 1150416)
  • Spanish National Cancer Research Centre
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
Keywords
adrenarche, galanin receptor 1, steroidogenesis, polygenic risk score, genetic factors, children, adrenal androgens, puberty timing, Chilean children
MeSH terms
Adolescent, Child, Child, Preschool, Chile, Female, Humans, Male, Risk Factors, Sulfates, Cohort Studies, Dehydroepiandrosterone Sulfate, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review